Beta-Blocker Dosing in Adults
For heart failure with reduced ejection fraction (HFrEF), start bisoprolol 1.25 mg once daily, carvedilol 3.125 mg twice daily, or metoprolol succinate 12.5-25 mg once daily, then double the dose every 2 weeks targeting bisoprolol 10 mg daily, carvedilol 25-50 mg twice daily, or metoprolol succinate 200 mg daily. 1, 2, 3
Evidence-Based Beta-Blockers and Target Doses
Only three beta-blockers have proven mortality reduction in heart failure and should be used preferentially 1, 3:
| Beta-Blocker | Starting Dose | Target Dose | Frequency |
|---|---|---|---|
| Bisoprolol | 1.25 mg | 10 mg | Once daily |
| Carvedilol | 3.125 mg | 25-50 mg* | Twice daily |
| Metoprolol succinate (CR/XL) | 12.5-25 mg | 200 mg | Once daily |
*50 mg twice daily for patients >85 kg 1
This is NOT a class effect—other beta-blockers have not demonstrated the same mortality benefit and should not be substituted 1, 3.
Titration Protocol
- Double the dose at minimum 2-week intervals 1
- Aim for target doses shown in clinical trials, or the highest tolerated dose 1
- Monitor heart rate, blood pressure, clinical status (congestion signs, body weight) at each titration 1
- Check blood chemistry 1-2 weeks after initiation and after final dose titration 1
- Remember: some beta-blocker is better than no beta-blocker 1
Hypertension Dosing
For hypertension without heart failure 4, 5, 6:
- Atenolol: 25-100 mg twice daily (reduce in severe renal dysfunction)
- Metoprolol tartrate: 100-200 mg twice daily
- Metoprolol succinate: 50-200 mg once daily
- Bisoprolol: 2.5-10 mg once daily
- Carvedilol: 12.5-50 mg twice daily
Beta-blockers are NOT first-line for hypertension unless the patient has ischemic heart disease or heart failure 4, 5, 6.
Supraventricular Tachycardia Dosing
For ongoing SVT management 7, 8:
- Atenolol: 25-50 mg daily, maximum 100 mg daily
- Metoprolol tartrate: 25 mg twice daily, maximum 200 mg twice daily
- Metoprolol succinate: 50 mg daily, maximum 400 mg daily
- Nadolol: 40 mg daily, maximum 320 mg daily (reduce with renal impairment)
- Propranolol: 30-60 mg daily (divided or long-acting), maximum 40-160 mg daily
Critical Adjustments for Comorbidities
Renal Dysfunction
Atenolol, nadolol, and acebutolol require dose reduction as they are renally eliminated 9, 10. Bisoprolol has balanced hepatic/renal clearance (50/50) and requires less adjustment—maximum 2-fold increase in half-life with single organ failure 10.
Metoprolol, propranolol, and carvedilol are hepatically metabolized and do not require renal dose adjustment 9, 10.
Hepatic Dysfunction
Reduce doses of metoprolol, propranolol, and carvedilol due to increased bioavailability from reduced first-pass metabolism 9, 10. Consider bisoprolol for balanced elimination 10.
Asthma/COPD
Absolute contraindication: non-selective beta-blockers (propranolol, nadolol, timolol, labetalol) 11, 12. Oral timolol and IV propranolol significantly increase asthma attacks (RR 3.35 and 10.19 respectively) 12.
Cardioselective beta-blockers (bisoprolol, metoprolol, atenolol, nebivolol) are preferred if beta-blocker therapy is essential (e.g., post-MI, HFrEF) 7, 8, 11. Even cardioselective agents lose selectivity at higher doses—keep metoprolol ≤100 mg daily 11.
In patients with asthma history, avoid metoprolol, labetalol, and oxprenolol even if cardioselective, as they showed increased asthma attacks 12.
Bradycardia
Do not initiate if heart rate <60 bpm or presence of second/third-degree AV block without pacemaker 1, 7, 8. If heart rate drops <50 bpm with worsening symptoms during titration, halve the dose 1.
Elderly Patients
Use lower end of dose ranges for atenolol, metoprolol, and other agents 4, 13. Elderly patients achieved lower target doses in clinical practice but still benefit from beta-blocker therapy 14, 15.
Problem-Solving During Titration
Worsening Congestion
- Double diuretic dose first 1
- If ineffective, halve beta-blocker dose 1
- Review in 1-2 weeks; seek specialist advice if no improvement 1
Symptomatic Hypotension
- Reconsider nitrates, calcium channel blockers, other vasodilators 1
- If no congestion, reduce diuretic dose 1
- Asymptomatic low blood pressure does not require intervention 1
Heart Rate <50 bpm with Symptoms
- Halve beta-blocker dose (rarely stop completely) 1
- Review other rate-slowing drugs (digoxin, amiodarone, diltiazem) 1
- Obtain ECG to exclude heart block 1
Critical Warnings
Never abruptly discontinue beta-blockers—risk of rebound myocardial ischemia, infarction, and arrhythmias 1, 4, 5. Taper if discontinuation is absolutely necessary 1.
Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to additive bradycardia and heart block risk 4, 5, 16.
Do not use in decompensated heart failure or cardiogenic shock 1, 16. Initiate only after clinical stabilization and discontinuation of IV inotropes 3.
Real-World Dosing Gap
Clinical practice data show only 17.5% of carvedilol patients and 7.9% of metoprolol succinate patients reach target doses 14. The primary limitation is baseline heart rate—patients with lower baseline heart rates cannot tolerate higher doses 15. Heart rate control (target ~65 bpm) may be more important than achieving arbitrary target doses 15.